-
-
-
-
-
-
-
Adial Pharmaceuticals completes $2.86 million warrant inducement deal
-
-
-
-
-
-
-
Adial Pharmaceuticals files patent application for AD04 drug through 2045
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
-
-
-
-
-
-
430,619 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

